[A version of this item appears in: Dementia and Elderly Care: the Latest Evidence Newsletter (RWHT), Volume 3 Issue 3, October 2012].
The revised EFNS guidelines for Alzheimer’s Disease (AD) were published in 2010. The new EFNS dementia guidelines involve dementia syndromes other than AD, including vascular cognitive impairment, frontotemporal lobar degeneration, dementia with Lewy bodies, corticobasal syndrome, progressive supranuclear palsy, Parkinson’s Disease dementia, Huntington’s Disease, prion diseases, normal-pressure hydrocephalus, limbic encephalitis and other toxic and metabolic disorders.
This document represents a peer-reviewed evidence-based statement for the guidance for clinical neurologists, geriatricians, psychiatrists and other specialist physicians. It offers a statement of minimum desirable standards for practice.
New recommendations and good practice points cover: clinical diagnosis, blood tests, neuropsychology, neuroimaging, electroencephalography, cerebrospinal fluid (CSF) analysis, genetic testing, disclosure of diagnosis, treatment of behavioural and psychological symptoms in dementia (BPSD), legal issues, counselling and support for caregivers.
Full Text Link (Note: This article requires a suitable Athens password, a journal subscription or payment for access).
Sorbi, S. Hort, J. Erkinjuntti, T. [et al] (2012). EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. European Journal of Neurology: the Official Journal of the European Federation of Neurological Societies, September 2012, Vol.19(9), pp.1159-1179. (Click here to view the PubMed abstract).